The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online June 17, 2009
The Journal of Immunology, 2009, 183, 59 -65
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0804046

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0804046v1
183/1/59    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gebe, J. A.
Right arrow Articles by Nepom, G. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gebe, J. A.
Right arrow Articles by Nepom, G. T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Restricted Autoantigen Recognition Associated with Deletional and Adaptive Regulatory Mechanisms1

John A. Gebe2,*, Betty B. Yue*, Kelly A. Unrath{dagger}, Ben A. Falk* and Gerald T. Nepom*,{ddagger}

* Benaroya Research Institute, Seattle WA 98101; {dagger} Department of Botany and Plant Pathology, Oregon State University, Corvallis, OR 97331; and {ddagger} Department of Immunology, University of Washington School of Medicine, Seattle WA 98195

Autoimmune diabetes (T1D) is characterized by CD4+ T cell reactivity to a variety of islet-associated Ags. At-risk individuals, genetically predisposed to T1D, often have similar T cell reactivity, but nevertheless fail to progress to clinically overt disease. To study the immune tolerance and regulatory environment permissive for such autoreactive T cells, we expressed TCR transgenes derived from two autoreactive human T cells, 4.13 and 164, in HLA-DR4 transgenic mice on a C57BL/6-derived "diabetes-resistant" background. Both TCR are responsive to an immunodominant epitope of glutamic acid decarboxylase 65555–567, which is identical in sequence between humans and mice, is restricted by HLA-DR4, and is a naturally processed self Ag associated with T1D. Although both TCR use the identical V{alpha} and Vβ genes, differing only in CDR3, we found stark differences in the mechanisms utilized in vivo in the maintenance of immune tolerance. A combination of thymic deletion (negative selection), TCR down-regulation, and peripheral activation-induced cell death dominated the phenotype of 164 T cells, which nevertheless still maintain their Ag responsiveness in the periphery. In contrast, 4.13 T cells are much less influenced by central and deletional tolerance mechanisms, and instead display a peripheral immune deviation including differentiation into IL-10-secreting Tr1 cells. These findings indicate a distinct set of regulatory alternatives for autoreactive T cells, even within a single highly restricted HLA-peptide-TCR recognition profile.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This research was supported by National Institutes of Health Grant AI050864 and United States Army Medical Research Acquisition Activity Grant PR064261.

2 Address correspondence and reprint requests to Dr. John A. Gebe, Department of Diabetes, Benaroya Research Institute, 1201 9th Avenue, Seattle, WA 98101. E-mail address: jgebe{at}benaroyaresearch.org

3 Abbreviations used in this paper: Treg, regulatory T cell; GAD, glutamic acid decarboxylase; T1D, type 1 diabetes.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.